Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is among the best fast money stocks to buy now. Analysts at JMP Securities have reaffirmed their ‘Market Outperform’ rating on Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), while raising the price target to $143 from$86, implying an upside potential of over 200% from the current levels. This confidence follows the company’s successful approval of Palsonify. The firm notes that Palsonify, an oral SST2 agonist designed for acromegalic adults who aren’t fit for ...